Researchers have announced successful results of a clinical trial for a commonly prescribed weight-loss drug called liraglutide. In adults who are overweight or have obesity combined with high cardiovascular risk, once-daily liraglutide combined with lifestyle interventions significantly lowered two types of fat that have been associated with risk to heart health: visceral fat and ectopic fat.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210804123709.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/08/210804123709.htm
Common weight-loss drug successfully targets fat that can endanger heart health
![Common weight-loss drug successfully targets fat that can endanger heart health]()
Reviewed by cmakigo
on
August 05, 2021
Rating:
No comments:
Post a Comment